Investor Alert: Faruqi & Faruqi, LLP Announces Investigation on Behalf of Metagenomi Shareholders
Oct 1, 2024
Biotechnology Invest Information
Unicycive Therapeutics Announces Participation in H.C. Wainwright Investment Conference
Sep 6, 2024
Bionomics Limited to Exhibit at the H.C. Wainwright Global Investment Conference
Sep 4, 2024
Unicycive Therapeutics to Feature Prominently at ASN Kidney Week 2024
Aug 27, 2024
Boundless Bio, Inc. (BOLD) Presents a Buying Opportunity After Recent Dip
Aug 14, 2024
FDA Grants Anixa Biosciences' Individual Patient IND for Second Dose of CAR-T Ovarian Cancer Therapy
Jul 23, 2024
Gain Therapeutics Presents Key Data on GT-02287 at FENS Forum 2024
Jun 27, 2024
argenx Unfolds its Long-term Plan 'Vision 2030' to Bring Breakthrough Science to Thousands of Patients
Jun 18, 2024
Molecular Partners AG to Participate in The TD Cowen Radiopharmaceutical Innovation Summit
Jun 18, 2024
Gain Therapeutics Proposes Public Offering of Common Stock
Jun 14, 2024
Gain Therapeutics Sets Price for $11.0 Million Public Stock Offering
Jun 14, 2024
Eisai Submits LEQEMBI® (lecanemab-irmb) Biologics License Update to FDA for Early Alzheimer's Treatment – Biogen Stocks in Focus
Jun 10, 2024
CASI Pharmaceuticals Targets Stability with 'Hold' Rating from Investment Analysts
Jun 1, 2024
Puma Biotechnology PBYI Downgraded to Hold by StockNews.com Analysts
May 12, 2024
Belite Bio's Tinlarebant Gains Spotlight at ARVO 2024 for Potential Treatment of Stargardt Disease and Dry AMD
May 2, 2024
Pluri Inc. Develops Cell-Based Coffee Innovation in Wake of Fluctuating Coffee Market Conditions
Mar 21, 2024
Charles River (CRL) Anticipated to Reveal Growth in Q4 Earnings
Feb 2, 2024
Agricultural Biotechnology Market on the Rise: Expected to Hit USD 64.7 Billion by 2031
Jan 20, 2024
Novartis Scemblix® Outperforms Traditional TKIs in Phase III CML Trial
Jan 8, 2024
Molecular Partners and Orano Med Forge Partnership for Novel Radio-DARPin Therapies Development
Jan 6, 2024
Investor Alert: Deadline Approaches in SCYNEXIS (NASDAQ:SCYX) Class Action Lawsuit
Dec 27, 2023
The Pioneering Developments Reshaping Investment Landscapes
Dec 26, 2023
Microbix Reports Financial Performance for Fiscal Year 2023
Dec 22, 2023
Zealand Pharma Enhances Board with Pharmaceutical Industry Stalwarts Enrique Conterno and Elaine Sullivan
Dec 1, 2023
Sernova Granted FDA Orphan Drug and Rare Pediatric Disease Designations for Hemophilia A Treatment
Nov 28, 2023
PharmAbcine's PMC-403 Shows Promise in Preclinical Study for Idiopathic Systemic Capillary Leak Syndrome
Nov 24, 2023
Rosen Law Firm Advocates for SCYNEXIS Investors Ahead of Legal Deadline
Nov 19, 2023
Microbix to Engage with Investors at the Upcoming Florida Capital Event Conference
Nov 18, 2023
SCYNEXIS Rating Adjustment: Downgraded to Hold
Nov 17, 2023
IHG PAS Partners with SOPHiA GENETICS to Further Male Infertility Research
Nov 17, 2023
Olink Holding AB Announces Q3 2023 Financial Performance
Nov 16, 2023
Athira Pharma Showcases Neuroprotective Properties of Fosgonimeton in Alzheimer's Disease Models
Nov 16, 2023
Yield10 Bioscience's Stacked Herbicide Tolerant Camelina Granted Planting and Breeding Approval in U.S.
Nov 15, 2023
Aeglea BioTherapeutics AGLE Receives Sell Rating Amid Market Dynamics
Nov 13, 2023
vTv Therapeutics Receives a 'Hold' Rating from StockNews.com Analysts
Nov 12, 2023
ROSEN, Trial Attorneys Urge SCYNEXIS Investors to Act Before Critical Securities Class Action Deadline - SCYX
Nov 12, 2023
GENFIT Announces Third Quarter 2023 Financial Outcomes and Update on R&D Progress
Nov 10, 2023
PetVivo Holdings, Inc. Set to Unveil Q2 Financial Results and Conduct a Conference Call
Nov 9, 2023
Pasithea Therapeutics Advances ALS Treatment with New Lead Candidate PAS-003 Targeting α5β1 Integrin
Nov 9, 2023
Catalyst Pharmaceuticals Delivers Mixed Q3 Results While Raising 2023 Outlook
Nov 9, 2023